Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNO 1030 (Imupret) for Mild COVID-19
NCT04797936Phase 4Completed
- Sponsor
- Ivano-Frankivsk National Medical University
- Start
- May 2020
- Primary completion
- Dec 2020
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
A Phase 4 trial of Imupret in coronavirus disease 2019 (COVID-19), sponsored by Ivano-Frankivsk National Medical University. Started May 2020; status: completed.
02
Drugs
Imupret
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04797936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04797936.